Ribociclib: How This Drug Is Changing Breast Cancer Treatment
Ribociclib is a targeted therapy that extends survival for women with advanced hormone receptor-positive breast cancer. Used with hormone drugs, it slows tumor growth with fewer side effects than chemo.